| pubmed-article:302312 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:302312 | lifeskim:mentions | umls-concept:C0023516 | lld:lifeskim |
| pubmed-article:302312 | lifeskim:mentions | umls-concept:C1515138 | lld:lifeskim |
| pubmed-article:302312 | lifeskim:mentions | umls-concept:C0020963 | lld:lifeskim |
| pubmed-article:302312 | lifeskim:mentions | umls-concept:C0019627 | lld:lifeskim |
| pubmed-article:302312 | lifeskim:mentions | umls-concept:C0205246 | lld:lifeskim |
| pubmed-article:302312 | lifeskim:mentions | umls-concept:C1705920 | lld:lifeskim |
| pubmed-article:302312 | lifeskim:mentions | umls-concept:C0205369 | lld:lifeskim |
| pubmed-article:302312 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:302312 | lifeskim:mentions | umls-concept:C0205430 | lld:lifeskim |
| pubmed-article:302312 | lifeskim:mentions | umls-concept:C2349101 | lld:lifeskim |
| pubmed-article:302312 | lifeskim:mentions | umls-concept:C1998793 | lld:lifeskim |
| pubmed-article:302312 | lifeskim:mentions | umls-concept:C0173022 | lld:lifeskim |
| pubmed-article:302312 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:302312 | pubmed:dateCreated | 1977-10-31 | lld:pubmed |
| pubmed-article:302312 | pubmed:abstractText | Normal immunocompetent T lymphocytes can be induced into specific proliferation if confronted with the relevant alloantigen in vitro. Such mixed leuko-cyteculture-activated T lymphoblasts carring idiotypic receptors on their surface can be purified using velocity sedimentation and serve as immunogen if administered in adjuvant to the autologous host. Autoblast immunization can be shown to lead to specific, long-lasting unresponsiveness against the relevant alloantigens, while leaving reactivity against third-party antigens intact. When tested as to general validity, it could be shown to function in all species analyzed (mouse, rat, and guinea pig) as well as across both major and minor histocompatibility barriers. No negative side effects have been noted so far. It would thus seem clear that autoblast immunization using the above described scheme may serve as a general tool in inducing long-lasting, specific unresponsiveness in any species and across any histocompatibility barrier. | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:language | eng | lld:pubmed |
| pubmed-article:302312 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:302312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:302312 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:302312 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:302312 | pubmed:issn | 0022-1007 | lld:pubmed |
| pubmed-article:302312 | pubmed:author | pubmed-author:AnderssonRR | lld:pubmed |
| pubmed-article:302312 | pubmed:author | pubmed-author:WigzellHH | lld:pubmed |
| pubmed-article:302312 | pubmed:author | pubmed-author:BinzHH | lld:pubmed |
| pubmed-article:302312 | pubmed:author | pubmed-author:AnderssonL... | lld:pubmed |
| pubmed-article:302312 | pubmed:author | pubmed-author:AguetMM | lld:pubmed |
| pubmed-article:302312 | pubmed:author | pubmed-author:WightEE | lld:pubmed |
| pubmed-article:302312 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:302312 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:302312 | pubmed:volume | 146 | lld:pubmed |
| pubmed-article:302312 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:302312 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:302312 | pubmed:pagination | 1124-37 | lld:pubmed |
| pubmed-article:302312 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-A... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-M... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-A... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-G... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-R... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-S... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-K... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-G... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-I... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-I... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-L... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-C... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-A... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-I... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-C... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-H... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-I... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-T... | lld:pubmed |
| pubmed-article:302312 | pubmed:meshHeading | pubmed-meshheading:302312-D... | lld:pubmed |
| pubmed-article:302312 | pubmed:year | 1977 | lld:pubmed |
| pubmed-article:302312 | pubmed:articleTitle | Induction of specific immune unresponsiveness using purified mixed leukocyte culture-activated T lymphoblasts as autoimmunogen. I. Demonstration of general validity as to species and histocompatibility barriers. | lld:pubmed |
| pubmed-article:302312 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:302312 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:302312 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:302312 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:302312 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:302312 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:302312 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:302312 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:302312 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:302312 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:302312 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:302312 | lld:pubmed |
